Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction

Reproductive BioMedicine Online

Volumn 26, Issue 1, 2013, Pages 62-67

  Bonetti, Tatiana C S ^a,b,d   Borges, Edson ^a   Braga, Daniela P A F ^b,c   Iaconelli, Assumpto ^a,c   Kleine, Joao P ^a,b   Silva, Ismael Dcg ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fertility Assisted Fertilization Center   (Brazil)

^c Educational and Research Center in Assisted Reproduction   (Brazil)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Embryo quality; Follicular fluid; ICSI; SRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ADULT; ARTICLE; BODY MASS; EMBRYO CELL; EMBRYO DEVELOPMENT; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE; OVARY FOLLICLE FLUID;

EID: 84874107420     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.10.001     Document Type: Article

References (33)

1. Bierhaus, A., Humpert, P.M., Stern, D.M., Arnold, B., Nawroth, P.P., 2005. Advanced glycation end product receptor-mediated cellular dysfunction. Ann. N. Y. Acad. Sci. 1043, 676-680.
2. Brett, J., Schmidt, A.M., Yan, S.D., Zou, Y.S., Weidman, E., Pinsky, D., Nowygrod, R., Neeper, M., Przysiecki, C., Shaw, A., Migheli, A., Stern, D., 1993. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143, 1699-1712.
3. Bucciarelli, L.G., Wendt, T., Rong, L., Lalla, E., Hofmann, M.A., Goova, M.T., Taguchi, A., Yan, S.F., Yan, S.D., Stern, D.M., Schmidt, A.M., 2002. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell. Mol. Life Sci. 59, 1117-1128.
4. D'agati, V., Schmidt, A.M., 2010. RAGE and the pathogenesis of chronic kidney disease. Nat. Rev. Nephrol. 6, 352-360.
5. Diamanti-Kandarakis, E., Piperi, C., Kalofoutis, A., Creatsas, G., 2005. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 62, 37-43.
6. Diamanti-Kandarakis, E., Piperi, C., Patsouris, E., Korkolopoulou, P., Panidis, D., Pawelczyk, L., Papavassiliou, A.G., Duleba, A.J., 2007. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem. Cell Biol. 127, 581-589.
7. Diamanti-Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A.G., Panidis, D., 2008. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin. Endocrinol. (Oxf.) 69, 634-641.
8. Driancourt, M.A., Thuel, B., 1998. Control of oocyte growth and maturation by follicular cells and molecules present in follicular fluid. A review. Reprod. Nutr. Dev. 38, 345-362.
9. Fanchin, R., Mendez Lozano, D.H., Frydman, N., Gougeon, A., Di Clemente, N., Frydman, R., Taieb, J., 2007. Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J. Clin. Endocrinol. Metab. 92, 1796-1802.
10. Franchimont, P., Hazee-Hagelstein, M.T., Hazout, A., Frydman, R., Schatz, B., Demerle, F., 1989. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. I. Sex steroids. Fertil. Steril. 52, 1006-1011.
11. Fujii, E.Y., Nakayama, M., 2010. The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging. Fertil. Steril. 94, 694-700.
12. Germanova, A., Koucky, M., Hajek, Z., Parizek, A., Zima, T., Kalousova, M., 2010. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy. Clin. Biochem. 43, 442-446.
13. Geroldi, D., Falcone, C., Emanuele, E., D'angelo, A., Calcagnino, M., Buzzi, M.P., Scioli, G.A., Fogari, R., 2005. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J. Hypertens. 23, 1725-1729.
14. Hudson, B.I., Carter, A.M., Harja, E., Kalea, A.Z., Arriero, M., Yang, H., Grant, P.J., Schmidt, A.M., 2008. Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22, 1572-1580.
15. Jinno, M., Takeuchi, M., Watanabe, A., Teruya, K., Hirohama, J., Eguchi, N., Miyazaki, A., 2011. Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology. Hum. Reprod. 26, 604-610.
16. Maillard-Lefebvre, H., Boulanger, E., Daroux, M., Gaxatte, C., Hudson, B.I., Lambert, M., 2009. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology (Oxford) 48, 1190-1196.
17. Malickova, K., Jarosova, R., Rezabek, K., Fait, T., Masata, J., Janatkova, I., Zima, T., Kalousova, M., 2010. Concentrations of sRAGE in serum and follicular fluid in assisted reproductive cycles -a preliminary study. Clin. Lab. 56, 377-384.
18. Mukherjee, T.K., Reynolds, P.R., Hoidal, J.R., 2005. Differential effect of estrogen receptor alpha and beta agonists on the receptor for advanced glycation end product expression in human microvascular endothelial cells. Biochim. Biophys. Acta 1745, 300-309.
19. Mukhopadhyay, S., Mukherjee, T.K., 2005. Bridging advanced glycation end product, receptor for advanced glycation end product and nitric oxide with hormonal replacement/estrogen therapy in healthy versus diabetic postmenopausal women: a perspective. Biochim. Biophys. Acta 1745, 145-155.
20. Neeper, M., Schmidt, A.M., Brett, J., Yan, S.D., Wang, F., Pan, Y.C., Elliston, K., Stern, D., Shaw, A., 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998-15004.
21. Norata, G.D., Garlaschelli, K., Grigore, L., Tibolla, G., Raselli, S., Redaelli, L., Buccianti, G., Catapano, A.L., 2009. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr. Metab. Cardiovasc. Dis. 19, 129-134.
22. Oliver, E.A., Buhimschi, C.S., Dulay, A.T., Baumbusch, M.A., Abdel-Razeq, S.S., Lee, S.Y., Zhao, G., Jing, S., Pettker, C.M., Buhimschi, I.A., 2011. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia. J. Clin. Endocrinol. Metab. 96, 689-698.
23. Palermo, G., Joris, H., Devroey, P., Van Steirteghem, A.C., 1992. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 340, 17-18.
24. Park, S., Yoon, S.J., Tae, H.J., Shim, C.Y., 2011. RAGE and cardiovascular disease. Front. Biosci. 16, 486-497.
25. Ramasamy, R., Yan, S.F., Schmidt, A.M., 2009. RAGE: therapeutic target and biomarker of the inflammatory response -the evidence mounts. J. Leukoc. Biol. 86, 505-512.
26. Ramasamy, R., Yan, S.F., Schmidt, A.M., 2011. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann. N. Y. Acad. Sci. 1243, 88-102.
27. Revelli, A., Delle Piane, L., Casano, S., Molinari, E., Massobrio, M., Rinaudo, P., 2009. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod. Biol. Endocrinol. 7, 40.
28. Runesson, E., Ivarsson, K., Janson, P.O., Brannstrom, M., 2000. Gonadotropin-and cytokine-regulated expression of the chemokine interleukin 8 in the human preovulatory follicle of the menstrual cycle. J. Clin. Endocrinol. Metab. 85, 4387-4395.
29. Santilli, F., Vazzana, N., Bucciarelli, L.G., Davi, G., 2009. Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr. Med. Chem. 16, 940-952.
30. Schmidt, A.M., Yan, S.D., Yan, S.F., Stern, D.M., 2000. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 1498, 99-111.
31. Sharma, I., Dhawan, V., Saha, S.C., Rashmi, B., Dhaliwal, L.K., 2010. Implication of the RAGE-EN-RAGE axis in endometriosis. Int. J. Gynaecol. Obstet. 110, 199-202.
32. Tanaka, N., Yonekura, H., Yamagishi, S., Fujimori, H., Yamamoto, Y., Yamamoto, H., 2000. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 275, 25781-25790.
33. Vlassara, H., Fuh, H., Makita, Z., Krungkrai, S., Cerami, A., Bucala, R., 1992. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc. Natl. Acad. Sci. USA 89, 12043-12047.